As of September 15, 2026, WisdomTree Cloud Computing Fund (WCLD) trades at $41.26. RSI at 53 is in neutral territory, and the price is above its 50-day average of $37.78.
WisdomTree Cloud Computing Fund (WCLD)
WisdomTree Cloud Computing Fund NASDAQ
WCLD Price Analysis
Market Metrics
WCLD Fund Facts
WisdomTree Cloud Computing Fund is an exchange-traded fund that provides targeted exposure to companies involved in cloud software and related services. WisdomTree Cloud Computing Fund seeks to track the BVP Nasdaq Emerging Cloud Index, an equal-weighted index of emerging public companies focused on delivering cloud-based software to customers. The fund is designed to give investors access to a diversified group of businesses across software, platform, cybersecurity, data management, collaboration, and digital infrastructure segments that support cloud adoption.
Sector weights
Trailing returns vs category
| Period | WCLD | Category |
|---|---|---|
| YTD | 23.27% | 13.51% |
| 1 month | 21.73% | 19.10% |
| 3 months | 31.02% | 10.83% |
| 1 year | 20.68% | 54.99% |
| 3 years | 10.58% | 27.86% |
| 5 years | -6.66% | 9.93% |
| 10 years | N/A | 19.36% |
Fund reference data as of Sep 15, 2026. Expense ratio and net assets are reported by the fund; returns are total returns and can differ from price change.
WCLD Analysis
- Monitor the concentration risk in the Technology sector; consider diversifying if it exceeds your risk tolerance.
- Given the focus on emerging cloud companies, be prepared for higher volatility compared to broader market ETFs.
- Track the performance of the BVP Nasdaq Emerging Cloud Index for insights into the fund's underlying components.
- Evaluate the fund's performance against its category average, especially during periods of sector rotation.
Market Correlations
How this etf moves relative to other assets
Based on 1 year of daily price data. Correlations may vary over different time periods.
How does any other asset move with WCLD? One year of daily closes, Pearson correlation.
Key Statistics
| Yield | N/A |
|---|---|
| Day High | $41.33 |
| Day Low | $39.51 |
| 52 Week High | 43.54 |
| 52 Week Low | 23.89 |
Earnings & Growth Analysis
Key Risks
Technical Indicators
| RSI (14) | 53.25 |
|---|---|
| MACD | 0.56 |
| SMA 50 | 37.78 |
| SMA 200 | 32.25 |
WCLD Trade Plans
Specific entry, exit, and risk management levels
Long entry pick an entry style
Risk Management
Profit Targets (Based on Conservative Entry)
Growth of $10,000
A $10,000 investment in WCLD in September 2019 would be worth about $16,295 today, compared with about $25,529 for the same investment in the S&P 500 benchmark.
Compare with Another Ticker
Monte Carlo Projection (10yr)
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in WCLD today could grow to about $20,038 by 2036 in the base case, with a bull case near $91,932 and a bear case around $4,367. Projections are statistical simulations, not guarantees.
WCLD ETF Price Prediction: 2030
CleaRank's simulation projects a price near $54.48 for WCLD by 2030 in the base case, from $41.26 today (1.3x over 4 years). The downside path ends near $20.79. These are outcomes of a Monte Carlo simulation run on WCLD's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | Downside (10th pct) | Base case | Upside (90th pct) |
|---|---|---|---|
| 2027 | $27.32 | $44.23 | $71.60 |
| 2028 | $23.99 | $47.41 | $93.71 |
| 2029 | $22.06 | $50.83 | $117 |
| 2030 | $20.79 | $54.48 | $143 |
| 2031 | $19.89 | $58.41 | $172 |
| 2032 | $19.24 | $62.61 | $204 |
| 2033 | $18.76 | $67.12 | $240 |
| 2034 | $18.42 | $71.95 | $281 |
| 2035 | $18.18 | $77.12 | $327 |
| 2036 | $18.02 | $82.68 | $379 |
Method: 10,000 simulated price paths using WCLD's historical volatility and drift, re-run daily. The base case is the median path; the two outer columns are the 10th and 90th percentile outcomes, which widen with time because uncertainty compounds. Simulations are not guarantees, and past volatility does not predict future returns. This is analysis, not investment advice.